Guidelines for pharmacologic intervention in postmenopausal females and males ≥50 years of age

History of fracture of vertebrae (clinical or subclinical), hip, wrist, pelvis, or humerus.

T-score ≤–2.5 (DXA) at the lumbar spine, femoral neck, or total hip.*

T-score between –1 and –2.5 at the femoral neck or spine, and a 10-year probability of hip fracture ≥3% or a 10-year probability of any major osteoporosis-related fracture ≥20% based upon the United States-adapted WHO algorithm.

DXA: dual-energy x-ray absorptiometry; WHO: World Health Organization.

* Predictive value of isolated measurement of 1/3 radius varies with clinical context.

References:

Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97:1802.
LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2022.

Graphic 52512 Version 9.0

خرید پکیج

Guidelines for pharmacologic intervention in postmenopausal females and males ≥50 years of age